17 Questions Your Data Can Finally Answer Download Now

Commercial Observer Finance Forum Panel

CO Fall Financing Forum

As we start a new decade, industry experts must be increasingly adept at pivoting strategies in a continuously evolving playing field. This became ever more apparent in light of the market crisis that emerged in Q1 and is continuing through the fall. The ability to identify fleeting moments from long-term shifts is critical in determining which deals make sense in a rapidly changing climate. The New York Fall Financing CRE Forum discussed the impacts of the COVID-19 outbreak as they relate to commercial real estate finance, where it’s safe to invest, opportunities for yield, the shift to a lenders’ market and how firms are moving business forward in this new normal. Join our expert speakers as they discuss: – If there are any windows of opportunity with current market volatility – Which deals are moving forward and which are struggling – Domestic and foreign investor strategies – Key differentiating factors between competing finance sources – How strong commercial real estate is as an industry to withstand the impacts of this new crisis.

Real estate investments have been among the most lucrative investment sources in the past decade but as the market struggles to recover from a pandemic-induced recession, what asset types hold the strongest investment opportunities and who are the risk takers that will seek them out? This panel discussed emerging investment opportunities, risk-averse strategies and new investment hot spots like film studios, life sciences, e-commerce and industrial.

Panelists included:

  • Jeffrey Fastov, Senior Managing Director, Square Mile Capital Management LLC
  • Mike Sroka, CEO Dealpath
  • Laurie Grasso, Partner Hunton Andrews, Kurth LLP
  • Aaron Appel, Senior Managing Director, Walker & Dunlop, LLC
  • Alex Karnal, Partner and Managing Director, Deerfield
  • Jeff Mandel, Co-Head US Acquisitions and New Business, Tishman Spyer

You might also like

Schedule A Meeting

Get a personalized demo of Dealpath from one of our experts